Featured
Cancer survivors with loneliness face far higher depression risk
Home Air Oct 24, 2026
Home Air Oct 23, 2026
Sleep Zones Oct 22, 2026
Cancer survivors with loneliness face nearly three times the risk of depression, reveals a study...
A new study of nearly half a million people suggests that drinking black tea may...
Nigeria's health reforms face a key test as facilities lack critical resources like midwives and...
Read our latest Mold Alerts articles.
Oral JAK inhibitors significantly enhance hair regrowth in alopecia areata patients, offering promising treatment options.
New CT methods predict fibrosis progression and drug effects, offering insights for patients with progressive...
New treatment approved for lung cancer patients with ROS1-positive non–small cell lung cancer.
Abbott invests in advanced cancer testing to detect disease earlier and personalize treatments with innovative diagnostics.
Abbott invests in advanced cancer testing to detect disease earlier and personalize treatments with innovative diagnostics.
Sarah Romano named SS Innovations CFO, bringing finance experience to the role, as the company's new chief financial officer.
HistoSonics gains approval for its tissue treatment system to destroy tumors with sound waves, initially for liver tumors, using histotripsy...
Edwards settlement sees the medical device maker pay a $10 million FTC penalty after sidestepping antitrust review in its JC...
J&J wins FDA approval for a dual-energy ablation catheter treating atrial fibrillation, combining radiofrequency and pulsed field energy for enhanced...
Physicians struggle to use wearable data from patients due to reimbursement and workflow barriers, limiting its potential in everyday clinical...
Penumbra tests new stroke treatment device in clinical trial for M2 occlusions, aiming to improve outcomes for stroke patients.
Patient data breach at AdaptHealth exposes thousands of records, prompting SEC filing and raising concerns over cloud security in healthcare...
The proposed Medicare 340B rule cuts payments to hospitals and expands site-neutral policies for imaging services starting in 2027.
FDA device approvals are rising in 2026 as the agency clears more high‑risk devices, but review times lengthen, highlighting slower...